These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20384957)

  • 21. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
    Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
    Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
    [No Abstract]   [Full Text] [Related]  

  • 22. Voriconazole-induced photosensitivity.
    Malani AN; Aronoff DM
    Clin Med Res; 2008 Sep; 6(2):83-5. PubMed ID: 18801950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.
    Jain LR; Denning DW
    J Infect; 2006 May; 52(5):e133-7. PubMed ID: 16427702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management.
    Surowiec D; DePestel DD; Carver PL
    Pharmacotherapy; 2008 Jun; 28(6):719-29. PubMed ID: 18503400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical images: voriconazole-induced periostitis deformans.
    Becce F; Malghem J; Lecouvet FE; Vande Berg BC; Omoumi P
    Arthritis Rheum; 2012 Oct; 64(10):3490. PubMed ID: 22777747
    [No Abstract]   [Full Text] [Related]  

  • 26. The safety of voriconazole.
    Potoski BA; Brown J
    Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
    [No Abstract]   [Full Text] [Related]  

  • 27. Torsades de pointes associated with voriconazole use.
    Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
    Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
    Denning DW; Ribaud P; Milpied N; Caillot D; Herbrecht R; Thiel E; Haas A; Ruhnke M; Lode H
    Clin Infect Dis; 2002 Mar; 34(5):563-71. PubMed ID: 11807679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
    Mouas H; Lutsar I; Dupont B; Fain O; Herbrecht R; Lescure FX; Lortholary O;
    Clin Infect Dis; 2005 Apr; 40(8):1141-7. PubMed ID: 15791514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP
    Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voriconazole therapy in children with cystic fibrosis.
    Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
    J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].
    Isobe K; Muraoka S; Sugino K; Yamazaki Y; Kikuchi N; Hamanaka N; Takai Y; Shimizu K; Kimura K; Hiroi N; Shibuya K; Homma S
    Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):489-93. PubMed ID: 17644946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voriconazole-associated myositis.
    Shanmugam VK; Matsumoto C; Pien E; Rosen J; Kumar P; Whelton S; Steen V
    J Clin Rheumatol; 2009 Oct; 15(7):350-3. PubMed ID: 20009971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients.
    Haylett AK; Felton S; Denning DW; Rhodes LE
    Br J Dermatol; 2013 Jan; 168(1):179-85. PubMed ID: 22860570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
    Ally R; Schürmann D; Kreisel W; Carosi G; Aguirrebengoa K; Dupont B; Hodges M; Troke P; Romero AJ;
    Clin Infect Dis; 2001 Nov; 33(9):1447-54. PubMed ID: 11577374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A suspected case of voriconazole-induced lung injury].
    Ishikawa S; Yano S; Tokuda Y; Wakabayashi K; Kobayashi K; Ikeda T; Takeyama H
    Nihon Kokyuki Gakkai Zasshi; 2008 Apr; 46(4):319-24. PubMed ID: 18516997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lupus erythematosus-like lesions by voriconazole in an infant with chronic granulomatous disease.
    Gomez-Moyano E; Vera-Casaño A; Moreno-Perez D; Sanz-Trelles A; Crespo-Erchiga V
    Pediatr Dermatol; 2010; 27(1):105-6. PubMed ID: 20199430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent photopsia following course of oral voriconazole.
    Kadikoy H; Barkmeier A; Peck B; Carvounis PE
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):387-8. PubMed ID: 20653481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Voriconazole photosensitivity: 7 cases].
    Auffret N; Janssen F; Chevalier P; Guillemain R; Amrein C; Le Beller C
    Ann Dermatol Venereol; 2006 Apr; 133(4):330-2. PubMed ID: 16733446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Pascual A; Calandra T; Bolay S; Buclin T; Bille J; Marchetti O
    Clin Infect Dis; 2008 Jan; 46(2):201-11. PubMed ID: 18171251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.